Caitong International Asset Management Co., LTD Editas Medicine, Inc. Transaction History
Caitong International Asset Management Co., LTD
- $102 Billion
- Q4 2024
A detailed history of Caitong International Asset Management Co., LTD transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 286 shares of EDIT stock, worth $394. This represents 0.0% of its overall portfolio holdings.
Number of Shares
286
Previous 286
-0.0%
Holding current value
$394
Previous $363,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding EDIT
# of Institutions
228Shares Held
54.7MCall Options Held
425KPut Options Held
306K-
Black Rock Inc. New York, NY7.78MShares$10.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.82MShares$9.42 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.75MShares$3.79 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.16MShares$2.98 Million0.0% of portfolio
-
State Street Corp Boston, MA1.87MShares$2.58 Million0.0% of portfolio
About Editas Medicine, Inc.
- Ticker EDIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,737,200
- Market Cap $94.9M
- Description
- Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...